QA: Emmaus Life Sciences Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000822370_2023_Emmaus_Life_Sciences_Inc.pdf

Logs

Graph

Absolute values for 0000822370, Emmaus Life Sciences Inc.

  xvar xval
0 AssetsCurrent 6,289,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 75,000
3 remainder_Assets 41,861,000
4 LiabilitiesCurrent 54,323,000
5 LiabilitiesNoncurrent 24,267,000
6 remainder_Liabilities 3,726,000
7 CostOfGoodsAndServicesSold 2,588,000
8 SellingGeneralAndAdministrativeExpense 13,170,000
9 ResearchAndDevelopmentExpense 1,725,000
10 remainder_Expenses 7,553,000
11 remainder_Revenues 18,390,000
12 remainder_NetIncome -3,979,000
13 remainder_ComprehensiveNetIncome -2,364,000
  yvar yval
0 Assets 48,225,000
1 Liabilities 82,316,000
2 Expenses 25,036,000
3 Revenues 18,390,000
4 StockholdersEquity -34,091,000
5 NetIncome -10,625,000
6 ComprehensiveNetIncome -11,807,000
7 BaseVar 90,155,000
8 EconomicCapitalRatio -1.08

Edgar->Model Mapping

Feature Distribution

Change over Time